Based on our results, we suggest that measuring levels of HGF, CXCL9, IL10-RB, MCP-3 and EN-RAGE could be further evaluated in larger cohorts as biomarkers of a “pre-morbid state” for the susceptibility to severe COVID-19. The gene discussed is CXCL9; the disease is COVID-19.